• Recent news

  • Woulgan listed on UK Drug Tariff from 1 December 2017

    Woulgan’s listing on UK Drug Tariff has been brought forward by one month from January 1st 2018 to December 1st 2017 with a reimbursement price of 20 GBP. -We can now actively market the product in both community and in hospital settings, promoting Woulgan with healthcare personnel to try and get their…

    Continue reading

Latest presentation

Third quarter 2017 results

Loading video...

Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 14.4 million (21.1) in the third quarter of 2017, and a negative EBITDA of NOK 7.3 million (-5.9). Woulgan® generated sales of NOK 0.4 million during the third quarter. ArcticZymes had a slight reduction in sales compared to third quarter last year…

View more